Drug intelligence / Profile preview

glycine max leaf extract

Development stage: Unknown
Modality: Small Molecules
Administration: Oral, Topical

Overview

Glycine max leaf extract is a botanical extract derived from the leaves of the soybean plant (*Glycine max* L. Merr.). It is rich in phytochemicals, including kaempferol glycosides, isoflavones (such as genistin), pterocarpans, and flavonoids. The extract has been investigated for its potential therapeutic effects in managing metabolic disorders, including obesity, prediabetes, and hyperlipidemia. Its mechanism of action involves antioxidant and anti-inflammatory activities, as well as the modulation of lipid and glucose metabolism. While it is used as a dietary supplement and a cosmetic ingredient for skin conditioning, it is not currently approved as a pharmaceutical drug for specific medical indications.

Other names: soybean leaf extractGlycine max leaves extract

Beyond the preview

Go deeper on glycine max leaf extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on glycine max leaf extract.

Explore the full profile